According to a new research, the synthetic psilocybin included in magic mushrooms helps alleviate the symptoms and indicators of depression, according to the BBC. According to the study's findings, a medication based on a chemical in hallucinogenic mushrooms can lessen the signs and symptoms of severe depression for up to 12 weeks. Patients are put into a dreamy condition with a 25-mg psilocybin capsule, which increases the likelihood that psychological treatment will be effective.
However, the researchers warned that the short-term adverse effects might be terrifying and that assistance must always be available. According to experts, the news source added that more extensive studies with a much longer follow-up are still required.
According to new research, the synthetic psilocybin included in magic mushrooms helps alleviate the symptoms and indicators of depression, according to the BBC. According to the study's findings, a medication based on a chemical in hallucinogenic mushrooms can lessen the signs and symptoms of severe depression for up to 12 weeks. Patients are put into a dreamy condition with a 25-mg psilocybin capsule, which increases the likelihood that psychological treatment will be effective.
However, the researchers warned that the short-term adverse effects might be terrifying and that assistance must always be available. According to experts, the news source added that more extensive studies with a much longer follow-up are still required.
The Financial Times reports that there has been much discussion about using psychedelics to treat mental health disorders. There are now relatively few numbers that have received global regulatory approval for medicinal usage.
However, more businesses have recently investigated various psychedelic drug treatments for mental health issues. A step toward their regulation for medicinal usage is research.